Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Keith Stewart

Showing results (11-20 of 215) with videos related to

Pageof 22
Sort By:
The New England Journal of Medicine|July 31, 2024
A Belantamab Mafodotin Revival in Multiple Myeloma TherapySuzanne Trudel, A Keith Stewart
Blood|February 9, 2013
CarfilzomibK Martin Kortuem, A Keith Stewart
Mayo Clinic Proceedings|June 6, 2015
Clinical Implementation of Cardiovascular PharmacogenomicsNaveen L Pereira, A Keith Stewart
Hematology. American Society of Hematology. Education Program|December 17, 2009
ASH evidence-based guidelines: what is the role of maintenance therapy in the treatment of multiple myeloma?Irene M Ghobrial, A Keith Stewart
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|February 25, 2005
Advances in myeloma genetics and prospects for pharmacogenomic testing in multiple myelomaJaime O Claudio, A Keith Stewart
Future Oncology (London, England)|May 17, 2011
Carfilzomib: a novel second-generation proteasome inhibitorMeaghan L Khan, A Keith Stewart
International Journal of Biochemistry and Molecular Biology|October 18, 2011
What is the functional role of the thalidomide binding protein cereblon?Xiu-Bao Chang, A Keith Stewart
Cancer Cell|November 12, 2015
SnapShot: Multiple MyelomaEsteban Braggio, K Martin Kortüm, A Keith Stewart
Cancer Research|October 2, 2023
A Landmark Paper That Introduced Proteasome Inhibition in MyelomaAnup Joseph Devasia, Guido Lancman, A Keith Stewart
Mayo Clinic Proceedings|January 8, 2017
Introduction to the Symposium on Precision MedicineTimothy B Curry, Eric L Matteson, A Keith Stewart
Pageof 22

Showing results (11-20 of 215) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|July 31, 2024
A Belantamab Mafodotin Revival in Multiple Myeloma TherapySuzanne Trudel, A Keith Stewart
Blood|February 9, 2013
CarfilzomibK Martin Kortuem, A Keith Stewart
Mayo Clinic Proceedings|June 6, 2015
Clinical Implementation of Cardiovascular PharmacogenomicsNaveen L Pereira, A Keith Stewart
Hematology. American Society of Hematology. Education Program|December 17, 2009
ASH evidence-based guidelines: what is the role of maintenance therapy in the treatment of multiple myeloma?Irene M Ghobrial, A Keith Stewart
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice|February 25, 2005
Advances in myeloma genetics and prospects for pharmacogenomic testing in multiple myelomaJaime O Claudio, A Keith Stewart
Future Oncology (London, England)|May 17, 2011
Carfilzomib: a novel second-generation proteasome inhibitorMeaghan L Khan, A Keith Stewart
International Journal of Biochemistry and Molecular Biology|October 18, 2011
What is the functional role of the thalidomide binding protein cereblon?Xiu-Bao Chang, A Keith Stewart
Cancer Cell|November 12, 2015
SnapShot: Multiple MyelomaEsteban Braggio, K Martin Kortüm, A Keith Stewart
Cancer Research|October 2, 2023
A Landmark Paper That Introduced Proteasome Inhibition in MyelomaAnup Joseph Devasia, Guido Lancman, A Keith Stewart
Mayo Clinic Proceedings|January 8, 2017
Introduction to the Symposium on Precision MedicineTimothy B Curry, Eric L Matteson, A Keith Stewart
Pageof 22